Ofer Lavie

5.3k total citations
213 papers, 3.7k citations indexed

About

Ofer Lavie is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Ofer Lavie has authored 213 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Obstetrics and Gynecology, 64 papers in Reproductive Medicine and 49 papers in Surgery. Recurrent topics in Ofer Lavie's work include Endometrial and Cervical Cancer Treatments (58 papers), Ovarian cancer diagnosis and treatment (51 papers) and Uterine Myomas and Treatments (32 papers). Ofer Lavie is often cited by papers focused on Endometrial and Cervical Cancer Treatments (58 papers), Ovarian cancer diagnosis and treatment (51 papers) and Uterine Myomas and Treatments (32 papers). Ofer Lavie collaborates with scholars based in Israel, United States and United Kingdom. Ofer Lavie's co-authors include Yakir Segev, Gad Rennert, Ofer Gemer, Edmond Sabo, Evgeny Yakirevich, Murray B. Resnick, Eran Ben‐Arye, Uziel Beller, Ron Auslender and Madeleine Lemyre and has published in prestigious journals such as Journal of Clinical Oncology, Nano Letters and PLoS ONE.

In The Last Decade

Ofer Lavie

199 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ofer Lavie Israel 34 1.3k 1.1k 857 687 499 213 3.7k
Andrea Ciavattini Italy 34 2.1k 1.6× 1.5k 1.3× 522 0.6× 610 0.9× 702 1.4× 251 4.3k
Ting‐Chang Chang Taiwan 39 1.9k 1.5× 1.2k 1.1× 746 0.9× 900 1.3× 794 1.6× 165 4.3k
Mark A. Morgan United States 45 2.2k 1.7× 1.8k 1.6× 1.4k 1.6× 1.7k 2.5× 1.1k 2.3× 201 6.8k
Linda F. Carson United States 39 1.5k 1.2× 2.3k 2.0× 1.4k 1.6× 1.6k 2.4× 1.0k 2.1× 122 5.4k
Henrik Alfthan Finland 42 586 0.5× 1.2k 1.1× 803 0.9× 779 1.1× 1.5k 3.0× 135 5.7k
İbrahim Alkatout Germany 30 1.3k 1.0× 1.0k 0.9× 662 0.8× 1.3k 1.9× 280 0.6× 269 3.8k
Luigi Selvaggi Italy 39 2.8k 2.2× 2.5k 2.2× 438 0.5× 879 1.3× 436 0.9× 221 5.5k
Hao Lin Taiwan 28 696 0.6× 529 0.5× 389 0.5× 718 1.0× 722 1.4× 228 3.2k
Umberto Leone Roberti Maggiore Italy 35 2.1k 1.7× 2.4k 2.1× 253 0.3× 802 1.2× 177 0.4× 171 4.1k
Naohiro Kanayama Japan 35 1.2k 0.9× 277 0.2× 306 0.4× 301 0.4× 923 1.8× 252 4.4k

Countries citing papers authored by Ofer Lavie

Since Specialization
Citations

This map shows the geographic impact of Ofer Lavie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofer Lavie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofer Lavie more than expected).

Fields of papers citing papers by Ofer Lavie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ofer Lavie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofer Lavie. The network helps show where Ofer Lavie may publish in the future.

Co-authorship network of co-authors of Ofer Lavie

This figure shows the co-authorship network connecting the top 25 collaborators of Ofer Lavie. A scholar is included among the top collaborators of Ofer Lavie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ofer Lavie. Ofer Lavie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Nadav, et al.. (2024). Evaluation of sonographic and clinical measures in early versus late third trimester for birth weight prediction. International Journal of Gynecology & Obstetrics. 168(2). 774–782. 1 indexed citations
2.
3.
Ben‐Arye, Eran, Ofer Lavie, W. Heyl, et al.. (2023). Integrative Medicine for Ovarian Cancer. Current Oncology Reports. 25(6). 559–568. 7 indexed citations
4.
Cohen, Nadav, et al.. (2023). Pain and anxiety management with virtual reality for office hysteroscopy: systemic review and meta-analysis. Archives of Gynecology and Obstetrics. 309(4). 1127–1134. 7 indexed citations
5.
Helpman, Limor, Ram Eitan, Zvi Vaknin, et al.. (2023). Assessment of oncological safety and utility of hysteroscopy in high grade endometrial cancers: Results from an Israel gynecologic oncology group study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 293. 67–71. 2 indexed citations
6.
7.
Samuels, Noah, et al.. (2020). Association Between Physical Activity and Use of Complementary Medicine by Female Oncology Patients in an Integrative Palliative Care Setting. The Journal of Alternative and Complementary Medicine. 26(8). 721–728. 4 indexed citations
8.
Nahshon, Chen, Arie Bitterman, Riad Haddad, David Hazzan, & Ofer Lavie. (2020). Hazardous Postoperative Outcomes of Unexpected COVID‐19 Infected Patients: A Call for Global Consideration of Sampling all Asymptomatic Patients Before Surgical Treatment. World Journal of Surgery. 44(8). 2477–2481. 66 indexed citations
9.
Lavie, Ofer, et al.. (2019). Low-Risk Human Papillomavirus Types in Cervical Intraepithelial Neoplasia 2–3 and in Invasive Cervical Cancer Patients. Journal of Lower Genital Tract Disease. 23(4). 248–252. 11 indexed citations
10.
Ben‐Arye, Eran, Noah Samuels, & Ofer Lavie. (2018). Integrative Medicine for Female Patients with Gynecologic Cancer. The Journal of Alternative and Complementary Medicine. 24(9-10). 881–889. 6 indexed citations
11.
Ben‐Arye, Eran, et al.. (2018). Effect of a Complementary/Integrative Medicine Treatment Program on Taxane-Induced Peripheral Neuropathy. International Journal of Gynecological Cancer. 28(5). 1045–1049. 4 indexed citations
12.
Lavie, Ofer, David Edelman, Tally Levy, et al.. (2017). A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer. Archives of Gynecology and Obstetrics. 295(3). 751–761. 44 indexed citations
13.
Shai, Ayelet, et al.. (2013). Conservative Management for an Entero-Adnexal Fistula at Initial Presentation of Advanced Ovarian Carcinoma. Current Oncology. 20(1). 44–47. 3 indexed citations
14.
Lavie, Ofer, Mila Pinchev, Hedy S. Rennert, Yakir Segev, & Gad Rennert. (2013). The effect of statins on risk and survival of gynecological malignancies. Gynecologic Oncology. 130(3). 615–619. 81 indexed citations
15.
Gemer, Ofer, Ram Eitan, Michael Gdalevich, et al.. (2012). Can parametrectomy be avoided in early cervical cancer? An algorithm for the identification of patients at low risk for parametrial involvement. European Journal of Surgical Oncology. 39(1). 76–80. 39 indexed citations
16.
Gemer, Ofer, et al.. (2009). Diameter-by-Age Reference Curves for the Uterine Cervix by Computerized Tomography. Journal of Computer Assisted Tomography. 33(3). 405–407.
17.
Gemer, Ofer, Alon Ben Arie, Tally Levy, et al.. (2007). Lymphvascular space involvement compromises the survival of patients with stage I endometrial cancer: Results of a multicenter study. European Journal of Surgical Oncology. 33(5). 644–647. 45 indexed citations
18.
Goldberg, Hadassah, Robert C. Miller, Roxolyana Abdah‐Bortnyak, et al.. (2007). Outcome after combined modality treatment for uterine papillary serous carcinoma: A study by the Rare Cancer Network (RCN). Gynecologic Oncology. 108(2). 298–305. 38 indexed citations
19.
Hammerman, Cathy, et al.. (1998). Does pregnancy affect medical ethical decision making?. Journal of Medical Ethics. 24(6). 409–413. 2 indexed citations
20.
Lavie, Ofer, et al.. (1993). Maternal serum creatine kinase: A possible predictor of tubal pregnancy. American Journal of Obstetrics and Gynecology. 169(5). 1149–1150. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Ciavattini Breakdown of academic impact, for papers by Ting‐Chang Chang Breakdown of academic impact, for papers by Mark A. Morgan Breakdown of academic impact, for papers by Linda F. Carson Breakdown of academic impact, for papers by Henrik Alfthan Breakdown of academic impact, for papers by İbrahim Alkatout Breakdown of academic impact, for papers by Luigi Selvaggi Breakdown of academic impact, for papers by Hao Lin Breakdown of academic impact, for papers by Umberto Leone Roberti Maggiore Breakdown of academic impact, for papers by Naohiro Kanayama
Rankless by CCL
2026